FDA Import Refusal AEK-7869886-5/30003/1 — OLCARE LABORATORIES
The FDA refused shipment AEK-7869886-5/30003/1 from OLCARE LABORATORIES (India) on Nov 10, 2025. The refused product falls under Drugs and Biologics — LINAGLIPTIN (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Nov 10, 2025
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PDA66 LINAGLIPTIN (ANTI-DIABETIC)
- Charges
- 75